Monopar Therapeutics, Inc. (MNPR)
59.27
-1.72
(-2.82%)
USD |
NASDAQ |
May 15, 16:00
59.42
+0.15
(+0.25%)
After-Hours: 20:00
Monopar Therapeutics Total Liabilities (Quarterly) : 2.589M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 45.49M |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
| Plus Therapeutics, Inc. | 7.955M |
| Perspective Therapeutics, Inc. | 63.33M |
| AVITA Medical, Inc. | 74.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 137.98M |
| Shareholders Equity (Quarterly) | 135.39M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 56.05 |
| Net Debt Paydown Yield | -0.01% |